• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳香单药治疗不能清除小鼠体内的幽门螺杆菌感染。

Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice.

作者信息

Loughlin Michael F, Ala'Aldeen Dlawer A, Jenks Peter J

机构信息

Institute of Infections and Immunity, Floor C, West Block, University Hospital, Queen's Medical Centre, University of Nottingham, UK.

出版信息

J Antimicrob Chemother. 2003 Feb;51(2):367-71. doi: 10.1093/jac/dkg057.

DOI:10.1093/jac/dkg057
PMID:12562704
Abstract

OBJECTIVE

To determine the ability of mastic monotherapy to eradicate Helicobacter pylori infection from mice.

MATERIALS AND METHODS

The susceptibility of H. pylori SS1 to mastic was assessed by broth dilution determination of the MIC and MBC. Mice were inoculated intragastrically with either a suspension of H. pylori SS1 (n = 70) or brain-heart infusion broth alone (n = 10). Mice were given antimicrobial chemotherapy 4 weeks after infection and were administered the mouse equivalent of either 2 g of mastic twice daily for 7 days or a triple therapy regimen containing the mouse equivalent of 400 mg of metronidazole, 250 mg of clarithromycin and 20 mg of omeprazole twice daily for 7 days. Mice were killed either immediately or 1 month after the completion of treatment, and their stomachs cultured for H. pylori.

RESULTS

The mastic MIC and MBC of H. pylori SS1 were 7.80 and 31.25 mg/L, respectively. The triple therapy regimen eradicated infection from 19 of 20 SS1-infected mice. Mastic failed to eradicate infection from any of the 18 SS1-infected mice (P < 0.001) and there was no signifi- cant reduction in gastric bacterial load in mice treated with this regimen.

CONCLUSION

Despite reported beneficial effects in ulcer patients and the good in vitro activity of mastic against H. pylori, this compound is unable to eradicate H. pylori infection from mice.

摘要

目的

确定乳香单一疗法根除小鼠幽门螺杆菌感染的能力。

材料与方法

通过肉汤稀释法测定最低抑菌浓度(MIC)和最低杀菌浓度(MBC),评估幽门螺杆菌SS1对乳香的敏感性。给小鼠胃内接种幽门螺杆菌SS1悬液(n = 70)或仅接种脑心浸液肉汤(n = 10)。感染4周后给予小鼠抗菌化疗,每天两次给予相当于2 g乳香的剂量,持续7天,或给予含相当于400 mg甲硝唑、250 mg克拉霉素和20 mg奥美拉唑的三联疗法方案,每天两次,持续7天。在治疗结束后立即或1个月后处死小鼠,并对其胃进行幽门螺杆菌培养。

结果

幽门螺杆菌SS1的乳香MIC和MBC分别为7.80和31.25 mg/L。三联疗法方案根除了20只感染SS1的小鼠中的19只的感染。乳香未能根除18只感染SS1的小鼠中的任何一只的感染(P < 0.001),并且用该方案治疗的小鼠胃内细菌载量没有显著降低。

结论

尽管有报道称乳香对溃疡患者有有益作用,且其在体外对幽门螺杆菌有良好活性,但该化合物无法根除小鼠的幽门螺杆菌感染。

相似文献

1
Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice.乳香单药治疗不能清除小鼠体内的幽门螺杆菌感染。
J Antimicrob Chemother. 2003 Feb;51(2):367-71. doi: 10.1093/jac/dkg057.
2
Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection.奥美拉唑、甲硝唑和克拉霉素联合治疗与奥美拉唑/阿莫西林双联疗法治疗幽门螺杆菌感染的疗效比较。
Digestion. 1998 Nov-Dec;59(6):646-50. doi: 10.1159/000007569.
3
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.奥美拉唑在一种新的根除幽门螺杆菌的1周三联疗法中的疗效及最佳剂量
Eur J Gastroenterol Hepatol. 1995 Sep;7(9):835-40.
4
Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice.小鼠中甲硝唑敏感和耐药幽门螺杆菌感染的呋喃妥因联合疗法评估
Antimicrob Agents Chemother. 2000 Oct;44(10):2623-9. doi: 10.1128/AAC.44.10.2623-2629.2000.
5
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].[采用甲硝唑的新型一周三联疗法根除幽门螺杆菌:以克拉霉素或阿莫西林作为第二种抗生素]
Med Clin (Barc). 1998 Jan 17;110(1):1-5.
6
Mastic gum has no effect on Helicobacter pylori load in vivo.乳香对体内幽门螺杆菌载量没有影响。
J Antimicrob Chemother. 2003 Sep;52(3):522-3. doi: 10.1093/jac/dkg366. Epub 2003 Jul 29.
7
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.甲硝唑耐药水平对幽门螺杆菌根除成功的重要性。
Aliment Pharmacol Ther. 2004 Jun 15;19(12):1315-21. doi: 10.1111/j.1365-2036.2004.01959.x.
8
The effect of mastic gum on Helicobacter pylori: a randomized pilot study.乳香树胶对幽门螺杆菌的影响:一项随机试验研究。
Phytomedicine. 2010 Mar;17(3-4):296-9. doi: 10.1016/j.phymed.2009.09.010. Epub 2009 Oct 29.
9
Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice.在体内接触甲硝唑很容易诱导幽门螺杆菌产生耐药性,并降低小鼠根除治疗的疗效。
Antimicrob Agents Chemother. 1999 Apr;43(4):777-81. doi: 10.1128/AAC.43.4.777.
10
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.使用奥美拉唑、克拉霉素和甲硝唑或奥硝唑进行为期一周的治疗,随后使用奥美拉唑进行3周治疗,根除幽门螺杆菌的效果相同,且能治愈十二指肠溃疡。
Eur J Gastroenterol Hepatol. 1997 Dec;9(12):1185-9.

引用本文的文献

1
Fermented- extract ameliorate eradication rate and gastritis.发酵提取物可提高根除率并改善胃炎。
Food Sci Nutr. 2020 Dec 13;9(2):900-908. doi: 10.1002/fsn3.2055. eCollection 2021 Feb.
2
The Use of Pistacia Lentiscus Chia Resin Versus Omeprazole in Protecting Male Rats Peptic Mucosa Against Cold Restraint Stress.乳香黄连木树脂与奥美拉唑对雄性大鼠胃黏膜抗冷束缚应激的保护作用比较
J Crit Care Med (Targu Mures). 2020 May 6;6(2):100-110. doi: 10.2478/jccm-2020-0018. eCollection 2020 Apr.
3
Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond.
胃癌的预防:根除幽门螺杆菌及其他措施
Int J Mol Sci. 2017 Aug 3;18(8):1699. doi: 10.3390/ijms18081699.
4
Current knowledge on alleviating infections through the use of some commonly known natural products: bench to bedside.关于通过使用一些常见天然产物减轻感染的当前知识:从实验室到临床应用。
Integr Med Res. 2014 Sep;3(3):111-118. doi: 10.1016/j.imr.2014.04.001. Epub 2014 Apr 24.
5
Non-pharmacological treatment of Helicobacter pylori.幽门螺杆菌的非药物治疗
World J Gastrointest Pharmacol Ther. 2016 May 6;7(2):171-8. doi: 10.4292/wjgpt.v7.i2.171.
6
Therapy of Helicobacter pylori: present medley and future prospective.幽门螺杆菌的治疗:当前的混杂情况与未来展望
Biomed Res Int. 2014;2014:124607. doi: 10.1155/2014/124607. Epub 2014 Apr 1.
7
Labeling of tannic Acid with technetium-99m for diagnosis of stomach ulcer.用锝-99m标记鞣酸用于胃溃疡的诊断。
ISRN Pharm. 2011;2011:578570. doi: 10.5402/2011/578570. Epub 2011 Jul 19.
8
Chios mastic treatment of patients with active Crohn's disease.希俄斯乳香对活动性克罗恩病患者的治疗
World J Gastroenterol. 2007 Feb 7;13(5):748-53. doi: 10.3748/wjg.v13.i5.748.
9
In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori.希俄斯乳香提取物及其成分对幽门螺杆菌的体外和体内活性
Antimicrob Agents Chemother. 2007 Feb;51(2):551-9. doi: 10.1128/AAC.00642-06. Epub 2006 Nov 20.